抑制劑溶液
Metabolism
GPCR/GProtein
Neuroscience
Apoptosis
Chromatin/Epigenetic
TyrosineKinase/Adaptors
Microbiology/Virology
Angiogenesis
CellCycle/Checkpoint
Membranetransporter/Ionchannel
Immunology/Inflammation
DNADamage/DNARepair
Autophagy
CytoskeletalSignaling
StemCells
PI3K/Akt/mTORsignaling
Proteases/Proteasome
MAPK
JAK/STATsignaling
Endocrinology/Hormones
Others
更多…
| 產(chǎn)品編號 | 圖片 | 產(chǎn)品描述 | 分子式 | 加入購物車 | |
|---|---|---|---|---|---|
|
JW-55，99% | C25H26N2O5 | |||
|
|
|||||
|
HA-100，98% | C13H15N3O2S | |||
|
|
|||||
|
EX-527(S-enantiomer)，98% | C13H13ClN2O | |||
|
|
|||||
|
EX-527 (R-enantiomer)，98% | C13H13ClN2O | |||
|
|
|||||
|
NCH-51，99% | C20H26N2O2S2 | |||
|
|
|||||
|
DC-05，98% | C25H25N3O | |||
|
|
|||||
|
GSK5959,BRPF1抑制劑，98%(HPLC) | C22H26N4O3 | |||
|
|
|||||
|
(-)-INDOLACTAM V，99% | C17H23N3O2 | |||
|
|
|||||
|
MN-64，98% | C18H16O2 | |||
|
|
|||||
|
Histone Acetyltransferase Inhibitor II，98% | C20H16Br2O3 | |||
|
|
|||||
|
HDAC-IN-4，98% | C24H29N5O | |||
|
|
|||||
|
|
TC-H 106，98% | C20H25N3O2 | |||
|
|
|||||
|
N6-(P-AMINOBENZYL)ADENOSINE，98% | C17H20N6O4 | |||
|
|
|||||
|
UNC0379，97% | C23H35N5O2 | |||
|
|
|||||
|
UNC0631，≥98% | C37H61N7O2 | |||
|
|
|||||
